Lawrence W. Byers

1.2k total citations · 1 hit paper
28 papers, 919 citations indexed

About

Lawrence W. Byers is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry and Molecular Biology. According to data from OpenAlex, Lawrence W. Byers has authored 28 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Biochemistry and 6 papers in Molecular Biology. Recurrent topics in Lawrence W. Byers's work include Eicosanoids and Hypertension Pharmacology (8 papers), Hormonal Regulation and Hypertension (8 papers) and Birth, Development, and Health (5 papers). Lawrence W. Byers is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (8 papers), Hormonal Regulation and Hypertension (8 papers) and Birth, Development, and Health (5 papers). Lawrence W. Byers collaborates with scholars based in United States, Australia and Sweden. Lawrence W. Byers's co-authors include E. E. Muirhead, B Brooks, Fred Snyder, Merle L. Blank, Russell L. Prewitt, Byron E. Leach, Robert G. Heath, Keith A. Smith, James A. Pitcock and Iris M. Krupp and has published in prestigious journals such as Nature, American Journal of Psychiatry and Biochemical and Biophysical Research Communications.

In The Last Decade

Lawrence W. Byers

28 papers receiving 792 citations

Hit Papers

Antihypertensive activity of an alkyl ether analog of pho... 1979 2026 1994 2010 1979 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence W. Byers United States 13 306 225 224 152 147 28 919
Karen A. Munger United States 19 364 1.2× 308 1.4× 210 0.9× 201 1.3× 110 0.7× 41 1.2k
Tatsuo Satake Japan 19 622 2.0× 452 2.0× 151 0.7× 350 2.3× 84 0.6× 98 1.5k
D. V. Godin Canada 19 246 0.8× 214 1.0× 63 0.3× 114 0.8× 143 1.0× 35 871
Beverly Lorenzo United States 17 758 2.5× 228 1.0× 137 0.6× 59 0.4× 90 0.6× 20 1.3k
Sampath Parthasarathy United States 10 257 0.8× 161 0.7× 111 0.5× 125 0.8× 207 1.4× 12 1.1k
David Hosford France 18 330 1.1× 215 1.0× 72 0.3× 181 1.2× 85 0.6× 36 1.2k
T Satake Japan 18 362 1.2× 409 1.8× 202 0.9× 302 2.0× 99 0.7× 66 1.0k
Fuminori Masugi Japan 13 214 0.7× 129 0.6× 80 0.4× 110 0.7× 112 0.8× 38 540
R Locher Switzerland 16 277 0.9× 172 0.8× 55 0.2× 147 1.0× 159 1.1× 32 857
Walter Trizna United States 20 667 2.2× 288 1.3× 110 0.5× 198 1.3× 168 1.1× 43 1.4k

Countries citing papers authored by Lawrence W. Byers

Since Specialization
Citations

This map shows the geographic impact of Lawrence W. Byers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence W. Byers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence W. Byers more than expected).

Fields of papers citing papers by Lawrence W. Byers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence W. Byers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence W. Byers. The network helps show where Lawrence W. Byers may publish in the future.

Co-authorship network of co-authors of Lawrence W. Byers

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence W. Byers. A scholar is included among the top collaborators of Lawrence W. Byers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence W. Byers. Lawrence W. Byers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muirhead, E. E., B Brooks, & Lawrence W. Byers. (1994). SECRETION OF MEDULLIPIN I BY THE KIDNEY INVOLVES THE CYTOCHROME P-450 ENZYME SYSTEM. Journal of Hypertension. 12(2). 155???158–155???158. 3 indexed citations
2.
3.
Muirhead, E. E., David H. P. Streeten, Lawrence W. Byers, B Brooks, & E. Todd Schroeder. (1993). Lipomedullipinoma: A Source of Hypermedullipinemia. Blood Pressure. 2(3). 183–188. 3 indexed citations
4.
Muirhead, E. E., David H. P. Streeten, B Brooks, E. Todd Schroeder, & Lawrence W. Byers. (1992). Persistent Hypotension Associated with Hypermedullipinemia: A New Syndrome. Blood Pressure. 1(3). 138–148. 4 indexed citations
5.
Muirhead, E. E., B Brooks, & Lawrence W. Byers. (1992). Biologic Differences Between Vasodilator Prostaglandins and Medullipin I. The American Journal of the Medical Sciences. 303(2). 86–89. 7 indexed citations
6.
Muirhead, E. E., B Brooks, Lawrence W. Byers, Pamela Brown, & James A. Pitcock. (1991). SECRETION OF MEDULLIPIN I BY ISOLATED KIDNEYS PERFUSED UNDER ELEVATED PRESSURE. Clinical and Experimental Pharmacology and Physiology. 18(6). 409–417. 13 indexed citations
7.
Muirhead, E. E., Lawrence W. Byers, B Brooks, Pamela Brown, & James A. Pitcock. (1989). Biologic Contrasts Between Medullipin I and Vasoactive Glyceryl Compounds. The American Journal of the Medical Sciences. 298(2). 93–103. 9 indexed citations
8.
Muirhead, E. E., et al.. (1987). Rapid Communication: Selachyl Alcohol as an Oral Antihypertensive Agent: A Preliminary Note. The American Journal of the Medical Sciences. 294(5). 384–387. 1 indexed citations
9.
Muirhead, E. E., Björn Folkow, Lawrence W. Byers, et al.. (1983). Cardiovascular effects of antihypertensive polar and neutral renomedullary lipids.. Hypertension. 5(2_pt_2). 23 indexed citations
10.
Muirhead, E. E., Lawrence W. Byers, Björn Folkow, et al.. (1983). Antihypertensive polar and neutral renopapillary lipids. Which is a hormone?. Hypertension. 5(6_pt_3). V61–5. 12 indexed citations
11.
Muirhead, E. E., B Folkow, Lawrence W. Byers, et al.. (1983). Cardiovascular effects of antihypertensive renomedullary lipids (APRL and ANRL). Acta Physiologica Scandinavica. 117(3). 465–467. 31 indexed citations
12.
Smith, Keith A., Lawrence E. Cornett, James S. Norris, Lawrence W. Byers, & E. E. Muirhead. (1982). Blockade of alpha-adrenergic receptors by analogues of phosphatidylcholine. Life Sciences. 31(18). 1891–1902. 9 indexed citations
13.
Muirhead, E. E., et al.. (1981). Antihypertensive lipids from the kidney: alkyl ether analogs of phosphatidylcholine.. PubMed. 40(8). 2285–90. 23 indexed citations
14.
Muirhead, E. E., Lawrence W. Byers, D. M. Desiderio, et al.. (1981). Alkyl ether analogs of phosphatidylcholine are orally active in hypertensive rabbits.. Hypertension. 3(3_pt_2). I107–11. 26 indexed citations
15.
Muirhead, E. E., et al.. (1981). Derivation of Neutral Antihypertensive Lipid from Renal Venous Effluent in Rats. Clinical Science. 61(s7). 331s–333s. 3 indexed citations
16.
Smith, Keith A., Russell L. Prewitt, Lawrence W. Byers, & E. E. Muirhead. (1981). Analogs of phosphatidylcholine: alpha-adrenergic antagonists from the renal medulla.. Hypertension. 3(4). 460–470. 42 indexed citations
17.
Prewitt, Russell L., Byron E. Leach, Lawrence W. Byers, et al.. (1979). Antihypertensive polar renomedullary lipid, a semisynthetic vasodilator.. Hypertension. 1(3). 299–308. 67 indexed citations
18.
Muirhead, E. E., Wilton A. Rightsel, Byron E. Leach, et al.. (1977). Reversal of hypertension by transplants and lipid extracts of cultured renomedullary interstitial cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(2). 162–72. 37 indexed citations
19.
Heath, Robert G., et al.. (1967). Schizophrenia as an Immunologic Disorder. Archives of General Psychiatry. 16(1). 24–24. 63 indexed citations
20.
Leach, Byron E., et al.. (1964). ‘Viractin’ : a Prophylactic Agent against Upper Respiratory Infections. Nature. 204(4960). 788–789. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026